Sex Hormone Levels, Breast Cancer Risk, and Cancer Receptor Status in Postmenopausal Women: the ORDET Cohort

被引:96
|
作者
Sieri, Sabina [1 ]
Krogh, Vittorio [1 ]
Bolelli, Gianfranco [7 ]
Abagnato, Carlo Alberto [7 ]
Grioni, Sara [1 ]
Pala, Valeria [1 ]
Evangelista, Alberto [1 ]
Allemani, Claudia [2 ]
Micheli, Andrea [3 ]
Tagliabue, Giovanna [4 ]
Schunemann, Holger J. [8 ]
Menard, Sylvie [5 ]
Berrino, Franco [6 ]
Muti, Paola [8 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Nutr Epidemiol Unit, I-20133 Milan, Italy
[2] Fdn IRCCS Ist Nazl Tumori, Analyt Epidemiol Unit, I-20133 Milan, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Descript Epidemiol & Hlth Planning Unit, I-20133 Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Canc Registry Div, I-20133 Milan, Italy
[5] Fdn IRCCS Ist Nazl Tumori, Labs & Dept Expt Oncol, Mol Biol Unit, I-20133 Milan, Italy
[6] Fdn IRCCS Ist Nazl Tumori, Etiol & Prevent Epidemiol Unit, I-20133 Milan, Italy
[7] Ctr Med Diagnost Emilia, Bologna, Italy
[8] Ist Regina Elena, Epidemiol & Prevent Unit, I-00161 Rome, Italy
关键词
METABOLIC-SYNDROME; ESTROGEN-RECEPTOR; GENE-EXPRESSION; ENDOGENOUS ESTROGENS; PROGESTERONE; ANDROGEN; TESTOSTERONE; CARCINOMAS; GROWTH;
D O I
10.1158/1055-9965.EPI-08-0808
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Endogenous sex hormone levels have been associated with increased breast cancer risk in postmenopausal women in several prospective studies. However, it remains unclear to what extent serum hormone-breast cancer associations differ with receptor status. Methods: Associations between serum sex hormone levels and breast cancer risk were assessed in a nested case-control study on postmenopausal women of the ORDET cohort. After a median follow-up of 13.5 years, 1.65 women developed breast cancer. Relative risks of developing breast cancer were estimated by conditional logistic regression. Results: Total and free testosterone levels were directly associated with breast cancer risk [relative risk, 3.28 (95% confidence interval, 1.93-5.55) and 2.86 (95% confidence interval, 1.66-4.94), respectively, for highest versus lowest quartile]. When relations between hormone level and risk of breast cancer expressing various receptor combinations were assessed, high total testosterone was significantly associated with increased risk of estrogen receptor-positive cancers, irrespective of progesterone receptor status. High total testosterone was also associated with increased risk of both human epidermal growth factor receptor 2 (HER2)-negative (HER2(-)) and HER2(+) cancers. High estradiol tended to be associated with increased risk of HER2- cancer and inversely associated with HER2(+) cancer, with significant (P = 0.027) heterogeneity between HER2(+) and HER2- cancers. However, there were relatively few HER2(+) cases. Conclusions: This study provides further evidence that high levels of circulating testosterone increase the risk of developing breast cancer in postmenopausal women. The cancers that develop are mainly estrogen receptor positive. Although HER2(+) and HER2- breast cancers were both associated with high total testosterone, they showed opposing associations with estrogen. (Cancer Epidemiol Biomarkers Prev 2009;18(1):169-76)
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [41] Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones
    Tworoger, SS
    Missmer, SA
    Barbieri, RL
    Willett, WC
    Colditz, GA
    Hankinson, SE
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (08): : 595 - 602
  • [42] Endogenous sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones
    Tworoger, SS
    Missmer, SA
    Colditz, GA
    Hankinson, SE
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1855S - 1855S
  • [43] Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women
    Fourkala, Evangelia-Ourania
    Zaikin, Alexey
    Burnell, Matthew
    Gentry-Maharaj, Aleksandra
    Ford, Jeremy
    Gunu, Richard
    Soromani, Christina
    Hasenbrink, Guido
    Jacobs, Ian
    Dawnay, Anne
    Widschwendter, Martin
    Lichtenberg-Frate, Hella
    Menon, Usha
    ENDOCRINE-RELATED CANCER, 2012, 19 (02) : 137 - 147
  • [44] Serum sex hormones and breast cancer risk factors in postmenopausal women
    Lamar, CA
    Dorgan, JF
    Longcope, C
    Stanczyk, FZ
    Falk, RT
    Stephenson, HE
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (04) : 380 - 383
  • [45] Breast cancer and hormone therapy in postmenopausal women
    Turner, LE
    Bundred, NJ
    BRITISH JOURNAL OF CANCER, 2004, 91 : S27 - S27
  • [46] Advanced glycation end products and breast cancer risk in a sample of the ORDET cohort
    Agnoli, Claudia
    Perlino, Federico
    Guerra, Giulia
    Quartiroli, Martina
    Vener, Claudia
    Mauri, Pierluigi
    de Palma, Antonella
    Venturelli, Elisabetta
    Sieri, Sabina
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2025, 40 (01): : 75 - 79
  • [47] Adherence to Diet Quality Indices and Breast Cancer Risk in the Italian ORDET Cohort
    Quartiroli, Martina
    Roncallo, Chiara
    Pala, Valeria
    Simeon, Vittorio
    Ricceri, Fulvio
    Venturelli, Elisabetta
    Pattaroni, Lara
    Sieri, Sabina
    Agnoli, Claudia
    NUTRIENTS, 2024, 16 (08)
  • [48] First pregnancy characteristics, postmenopausal breast density, and salivary sex hormone levels in a population at high risk for breast cancer
    Mockus, Mary
    Prebil, LeeAnn
    Ereman, Rochelle
    Dollbaum, Charles
    Powell, Mark
    Yau, Christina
    Benz, Christopher C.
    BBA CLINICAL, 2015, 3 : 189 - 195
  • [49] Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women
    Fournier, Agnes
    Mesrine, Sylvie
    Gelot, Amandine
    Fagherazzi, Guy
    Baglietto, Laura
    Clavel-Chapelon, Francoise
    Boutron-Ruault, Marie-Christine
    Chabbert-Buffet, Nathalie
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (28) : 3230 - +
  • [50] Is weight of the breast associated with hormone receptor expression in postmenopausal women with invasive breast cancer?
    Housmans, S
    Vanspauwen, R
    Christiaens, MR
    Drijkoningen, M
    Vergote, I
    Berteloot, P
    Amant, F
    Tonglet, R
    Neven, P
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S89 - S90